DIUPRES-250 Trademark

Trademark Overview


On Thursday, November 12, 1970, a trademark application was filed for DIUPRES-250 with the United States Patent and Trademark Office. The USPTO has given the DIUPRES-250 trademark a serial number of 72375888. The federal status of this trademark filing is EXPIRED as of Saturday, November 23, 2002. This trademark is owned by MERCK & CO., INC.. The DIUPRES-250 trademark is filed in the Pharmaceutical Products category with the following description:

MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF HYPERTENSION

General Information


Serial Number72375888
Word MarkDIUPRES-250
Filing DateThursday, November 12, 1970
Status900 - EXPIRED
Status DateSaturday, November 23, 2002
Registration Number0929440
Registration DateTuesday, February 22, 1972
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMEDICINAL PREPARATION FOR USE IN THE TREATMENT OF HYPERTENSION
Pseudo Mark250

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code9 - Expired
Class Status DateSaturday, November 23, 2002
Primary Code018
First Use Anywhere DateFriday, January 2, 1959
First Use In Commerce DateFriday, January 2, 1959

Trademark Owner History


Party NameMERCK & CO., INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRAHWAY, NJ 07065

Trademark Events


Event DateEvent Description
Saturday, November 23, 2002CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, November 21, 1991REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, September 6, 1991REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Monday, April 11, 1977REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.